CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,117 enrolled
Drug / intervention
Data collection +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01391819
NCT01391819N/ACompleted
CompareCT.gov

An Epidemiological Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children

GlaxoSmithKline·interventional·Posted Jul 12, 2011·Updated Jun 25, 2019

In Brief

A clinical study evaluating Data collection and Blood sample collection for Dengue. Completed, enrolled 2,117 participants across 1 site.

Detailed Summary

The aim of this study is to establish an active surveillance in order to generate dengue disease burden estimates including incidence rates, prevalence data, clinical presentation and cost of illness in Forteleza (Brazil).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDengue
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 12, 2011
Enrollment StartSep 6, 2011
Primary CompletionJan 30, 2015
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 15.0 years ago

Interventions

Data collectionother

Socio-demographic information, medical history, yellow fever vaccination history and dengue suspicion data collection.

Blood sample collectionprocedure

A blood sample will be collected at each of the three scheduled study visits and any time during the study that dengue is suspected. Samples collected at scheduled visits will be tested for anti-dengue antibodies. Samples collected at visits for dengue suspicion will be tested for dengue diagnosis.